Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

GeoVax Labs (GOVX) Operating Expenses (2016 - 2025)

GeoVax Labs' Operating Expenses history spans 16 years, with the latest figure at $4.4 million for Q4 2025.

  • Quarterly results put Operating Expenses at $4.4 million for Q4 2025, down 51.77% from a year ago — trailing twelve months through Dec 2025 was $24.1 million (down 17.08% YoY), and the annual figure for FY2025 was $24.1 million, down 17.08%.
  • Operating Expenses for Q4 2025 was $4.4 million at GeoVax Labs, down from $6.4 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $13.9 million in Q4 2021 to a low of $1.6 million in Q2 2021.
  • The 5-year median for Operating Expenses is $5.6 million (2022), against an average of $5.7 million.
  • The sharpest move saw Operating Expenses soared 775.47% in 2021, then crashed 61.27% in 2022.
  • Year by year, Operating Expenses stood at $13.9 million in 2021, then crashed by 61.27% to $5.4 million in 2022, then soared by 42.81% to $7.7 million in 2023, then grew by 19.69% to $9.2 million in 2024, then plummeted by 51.77% to $4.4 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $4.4 million, $6.4 million, and $6.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.